Xaluritamig

A4DAB303 | Cancer | Phase-III
STEAP1;CD3
G1;non-canonical / TBD
Amgen Xencor BeiGene
Phase-III
Bispecific Mixed mAb and scFv
AMG-509 AMG509 AMG 509
—
IMGT PubChem (471299029) PubChem (474492365) PubChem (507750352) Thera-SAbDab YAbS
Avg A4D Score
-0.5728
Score Range
-0.57
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB303_8ucd_H_L 8ucd 100% -0.5728 7.0 4.0 -0.0591 -0.7085